Frequency and Incidence of Carney Complex Manifestations: A Prospective Multicenter Study With a Three-Year Follow-Up

Archive ouverte

Espiard, Stéphanie | Vantyghem, Marie-Christine | Assié, Guillaume | Cardot-Bauters, Catherine | Raverot, Gerald | Brucker-Davis, Françoise | Archambeaud-Mouveroux, Françoise | Lefebvre, Hervé | Nunes, Marie-Laure | Tabarin, Antoine | Lienhardt, Anne | Chabre, Olivier | Houang, Muriel | Bottineau, Muriel | Stroër, Sebastian | Groussin, Lionel | Guignat, Laurence | Cabanes, Laure | Feydy, Antoine | Bonnet, Fidéline | North, Marie Odile | Dupin, Nicolas | Grabar, Sophie | Duboc, Denis | Bertherat, Jérôme

Edité par CCSD ; Endocrine Society -

International audience. Abstract Introduction Carney Complex (CNC) is a rare multiple endocrine and nonendocrine neoplasia syndrome. Manifestations and genotype-phenotype correlations have been described by retrospective studies, but no prospective study evaluating the occurrence of the different manifestations has been available so far. Methods This multicenter national prospective study included patients with CNC, primary pigmented nodular adrenal disease (PPNAD), or a pathogenic PRKAR1A mutation; after a full initial workup, participants were followed for 3 years with annual standardized evaluation. Results The cohort included 70 patients (50 female/20 male, mean age 35.4 ± 16.7 years, 81% carrying PRKAR1A mutation). The initial investigations allowed identification of several manifestations. At the end of the 3-year follow-up, the newly diagnosed manifestations of the disease were subclinical acromegaly in 6 patients, bilateral testicular calcifications in 1 patient, and cardiac myxomas in 2 patients. Recurrences of cardiac myxomas were diagnosed in 4 patients during the 3-year follow-up study period. Asymptomatic abnormalities of the corticotroph and somatotroph axis that did not meet criteria of PPNAD and acromegaly were observed in 11.4% and 30% of the patients, respectively. Patients carrying the PRKAR1A c.709-7del6 mutation had a mild phenotype. Conclusion This study underlines the importance of a systematic follow-up of the CNC manifestations, especially a biannual screening for cardiac myxoma. By contrast, regular screening for the other manifestations after a first extensive workup could be spread out, leading to a lighter and more acceptable follow-up schedule for patients. These are important results for recommendations for long-term management of CNC patients.

Consulter en ligne

Suggestions

Du même auteur

Evaluation of the occurrence of the manifestations of Carney complex in a french cohort of 70 patients during a three years standardized follow-up

Archive ouverte | Espiard, Stéphanie | CCSD

International audience. IntroductionThe Carney Complex is a multiple endocrine and non endocrine neoplasia mostly due to PRKAR1A mutations. Spectrum of manifestations and genotypephenotype correlations have been pre...

Carney complex predisposes to breast cancer: prospective study of 50 women.

Archive ouverte | Vaduva, Patricia | CCSD

International audience. Carney complex (CNC) is a rare genetic syndrome, mostly due to germline loss-of-function pathogenic variants in PRKAR1A. Carney complex includes pigmented skin lesions, cardiac myxomas, prima...

Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients

Archive ouverte | Bouys, Lucas | CCSD

International audience. Abstract Objective Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a heterogeneous disease characterized by adrenal macronodules and variable levels of cortisol excess, with not...

Chargement des enrichissements...